Alpha Registry
Claim a profile

Person profile

Public information reviewed

Sukumar Nagendran, M.D.

Role

President and Head of Research and Development at Taysha Gene Therapies, Inc. (NASDAQ: TSHA)

Board role

President, Head of Research and Development and Director · Taysha Gene Therapies, Inc. (NASDAQ: TSHA)

Taysha Gene Therapies, Inc. (NASDAQ: TSHA)

President, Head of Research and Development and Director · Current mandate

Board Director · Us Listed
FollowSave PDF
More
Reports & analysisAlpha Eval
Public sources
2 reviewed
Profile ownership
Not yet claimed
Last reviewed
Sep 13, 2026
View sources

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
21 current organization shown on this profile
Board positions
11 supported by public sources, 0 supplied by the profile owner
Committee roles
Not establishedNo committee role is currently confirmed by the cited sources
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Alpha has not published a narrative summary because the current public source set is not sufficient.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Executive appointments

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

President, Head of Research and Development and Director

Taysha Gene Therapies, Inc.

Current · start date not disclosed

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

Taysha Gene Therapies, Inc.

Open Taysha Gene Therapies, Inc. profile →

President and Head of Research and Development at Taysha Gene Therapies, Inc.

Start not stated → End not stated

current · source reported

Observed: 2026-09-16

President, Head of Research and Development and Director at Taysha Gene Therapies, Inc.

Start not stated → End not stated

current · source reported

Observed: 2026-09-16

Taysha Gene Therap…Taysha Gene Therapies, Inc.Sukumar Nagendran,…

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec Def 14aPublic profile sourceSupports President and Head of Research and Development at Taysha Gene Therapies, Inc. (NASDAQ: TSHA), President, Head of Research and Development and Director at Taysha Gene Therapies, Inc. (NASDAQ: TSHA), Executive title.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:sukumar-nagendran-m-d-taysha-gene-therapies-inc
Record version
public-0

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

Board membership · Source reportedServes on the board of Taysha Gene Therapies, Inc.1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Executive title · Source reportedExecutive title: President and Head of Research and Development1 source
Verification
Source reported
Confidence
95%
Last reviewed
Sep 13, 2026
View all sources2 records
  1. https://www.sec.gov/Archives/edgar/data/1806310/000119312526168525/d94391ddef14a.htm

    Sec Def 14a · Tier not stated · Reviewed Sep 13, 2026

    Supports: President and Head of Research and Development at Taysha Gene Therapies, Inc. (NASDAQ: TSHA) · President, Head of Research and Development and Director at Taysha Gene Therapies, Inc. (NASDAQ: TSHA) · Executive title

  2. https://www.sec.gov/Archives/edgar/data/1806310/000119312526168525/d94391ddef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership